Vela-Bahena LE, Vergara R, Vite L, Ramos C

Language: Spanish
References: 25
Page: 487-493
PDF size: 344.84 Kb.

ABSTRACT

Chagas disease is a problem of global public health. It is caused by the protozoan Trypanosoma cruzi, which is acquired through exposure to infected triatomine feces, blood transfusion, organ transplantation, orally, by laboratory accidents and congenitally (mother-child); the latter is a public health problem in endemic countries and is the most common form in non-endemic countries. In Mexico, there are few studies on congenital transmission of Chagas disease. The majority of pregnant women with Chagas disease are chronic and asymptomatic, and there is a risk of products with low birth weight and abortions, probleyet most infants are asymptomatic and treatment in pregnancy is contraindicated. Here, we report a case of a 24-year-old who was diagnosed with Chagas disease by donating blood and confirmed by the State Laboratory of Public Health. Before starting treatment, 13 weeks pregnancy was detected and followed up until the birth; mother was seropositive for Chagas disease and child was negative by parasitological studies. Breastfeeding was initiated at birth and one month, after consulting with experts, treating the mother began with benznidazole for 45 days; in general, the treatment was well tolerated, but the patient remained seropositive.

REFERENCES

1. Rassi A, Rassi A, Marin-Neto JA. Chagas disease. Lancet 2010;375:1388-1402.

2. World Health Organization. Chagas disease control and elimination. The Sixty-third World Health Assembly WHA63.20. World Health Organization, Geneva, Switzerland, 2010.

3. Carabarin-Lima A, González-Vázquez MC, Rodríguez-Morales O, Baylón-Pacheco L, Rosales-Encina JL, Reyes-López PA, Arce-Fonseca M. Chagas disease (American tripanosomiasis) in Mexico: An update. Acta Tropica 2013;127:126-135.

4. Viotti R, Vigliano C. Etiological treatment of chronic Chagas disease: neglected “evidence” by evidence-based medicine. Expert Rev Anti-Infect Ther 2007;5:717-726.

5. Carlier Y, Torrico F, Sosa-Estani S, Russomando G, Luquetti A, Freilij H, Albajar Vinas P. Congenital Chagas disease: recommendations for diagnosis, treatment and control of newborns, siblings and pregnant women. PLoS Neglected Tropical Diseases 2011;5:e1250.

6. Sosa-Estani S, Cura E, Velazquez E, Yampotis C, Segura EL. Etiological treatment of young women infected with Trypanosome cruzi, and prevention of congenital transmission. Rev Soc Bras Med Trop 2009;42:484-487.

7. Blanco SB, Segura EL, Cura EN, Chuit R, Tulián L, Flores I, Garbarino G, Villalonga JF, Gurtler RE. Congenital transmission of Trypanosoma cruzi: an operational outline for detecting and treating infected infants in northwestern Argentina. Trop Med Internatl Health 2000;5:293-301.

8. Oliveira I, Torrico F, Muñoz J, Gascón J. Congenital transmission of Chagas disease: a Clinical approach. Expert Rev Anti-infect Therapy 2010;8:945-956.

9. Cevallos AM, Hernandez R. Chagas disease: Pregnancy and congenital transmission. BioMed Res Internatl 2014;ID401864.

10. Moretti E, Basso B, Castro I, Carrizo Paez M, Chaul M, Barbieri G et al. Chagas´disease: study of congenital transmission in cases of acute maternal infection. Rev Soc Bras Med Trop 2005;38:53-55.

11. Muñoz J, Coll O, Juncosa T,Vergés M, del Pino M, Fumado V, et al. Prevalence and vertical transmission of Trypanosoma cruzi infection among pregnant Latin American women attending two maternity clinics in Barcelona, Spain. Clin Infect Dis 2009;48:1736-1740.

12. Rodriguez-Guerineau L, Posfay-Barbe KM, Monsonis- Cabedo M, Juncosa-Morros T, Diana A, Wyler-Lazarevic CA, et al. Pediatric Chagas disease in Europe. Pediatr Infect Dis J 2014;33:458-462.

13. Barona-Vilar C, Giménez-Martí MJ, Fraile T, González-Steinbauer C, Parada C, Gil-Brusola A, Bravo D, et al. Prevalence of Trypanosoma cruzi infection in pregnant Latin American women and congenital transmission rate in a non-endemic area: the experience of the Valencian Health Programme (Spain). Epidemiol Infect 2012;140:1896-1903.

14. Howard EJ, Xiong X, Carlier Y, Sosa-Estani S, Buekens P. Frequency of the congenital transmission of Trypanosoma cruzi: a systematic review and meta-analysis. BJOG 2014;121:22-33.

15. Diez CN, Manattini S, Zanuttini JC, Bottaso O, Marcipar I. Short Report. The value of molecular studies for the diagnosis of congenital Chagas disease in northeastern Argentina. Am J Trop Med Hyg 2008; 78:624-627.

16. De Rissio AM, Riarte RR, Martin García M, Esteva MI, Quaglino M, Ruíz AM. Congenital Trypanosoma cruzi infection: Efficacy of its monitoring in an urban reference health center in a non-endemic area of Argentina. Am J Trop Med Hyg 2010;82:838-845.

17. Torrico F, Alonso Vega C, Suárez E, Téllez T, Brutus L, Rodríguez P, Torrico MC, et al. Are maternal re-infections with Trypanosoma cruzi associated with higher morbidity and mortality of congenital Chagas disease. Trop Med Internatl Health 2006;11:628-635.

18. Russomando G. Transmisión congénita de la enfermedad de Chagas en el Paraguay. Mem Inst Invest Cienc Salud 2009; 5: 55-64

19. Guzman-Bracho C, Lahuerta S, Velasco-Castrejon O. Chagas disease. First congenital case report. Arch Med Res 1998;29:195-196.

20. Cardoso EJ, Valdez GC, Campos AC, de la Luz SR, Mendoza CR, Hernandez AP, Ramirez MH et al. Maternal fetal transmission of Trypanosoma cruzi: a problem of public health little studied in Mexico. Exp Parasitol 2012;131:425-432.

21. Garcia-Bournissen F, Moroni S, Marson ME, Moscatelli G, Mastrantonio G, Bisio M, Cornou L, Ballering G, Altcheh J. Limited infant exposure to benznidazole through breast milk during maternal treatment for Chagas disease. Arch Dis Child 2014;doi10.1136.

22. Altcheh J, Moscatelli G, Mastrantonio G, Moroni S, Giglio N, Marson ME, Ballering G, et al. Population pharmacokinetic study of benznidazole in pediatric Chagas disease suggests efficacy despite lower plasma concentrations than in adults. PLOS Negl Trop Dis 2014;8:e2907.

23. Imai K, Maeda T, Sayama Y, Mikita K, Fujikura Y, Misawa K, et al. Mother-to-child transmission of congential Chagas disease, Japan. Emerg Infect Dis 2014;20:146-148

24. Bisio M Altcheh J, Freilij H. Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS. Emerg Infect Dis 2013;19:1490-1492.

25. Altcheh J, Biancardi M, Lapeña A, Ballering G, Freilij H. Congenital Chagas disease: experience in the Hospital de Niños, Ricardo Gutiérrez, Buenos Aires, Argentina. Rev Soc Bras Med Trop 2005;38:41-45.